Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2025 | Radiotherapy considerations in young women with breast cancer

Icro Meattini • 8 May 2025
ESMO Breast 2025
Breast Cancer

Icro Meattini, MD, University of Florence, Florence, Italy, discusses key considerations for radiotherapy in young women with breast cancer, emphasizing the need for a multidisciplinary treatment approach. Factors such as age and BRCA mutation status can influence radiotherapy decisions, dose prescription and surgical planning. He also highlights the relevance of comparing breast-conserving therapy to mastectomy in BRCA carriers, as well as evaluating recurrence risk in younger patients, to further inform personalized treatment strategies. This interview took place at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Munich, Germany.

All content is owned by Magdalen Medical Publishing (MMP) and protected under international copyright laws. All rights reserved.

More from Icro Meattini

Early breast cancer: multimodal de-escalation strategies to reduce treatment burden safely
5:20
Early breast cancer: multimodal de-escalation strategies to reduce treatment burden safely
Icro Meattini • 10 Jul 2025
BRCA carrier status and radiation therapy in young patients with breast cancer
2:34
BRCA carrier status and radiation therapy in young patients with breast cancer
Icro Meattini • 30 May 2025
Moderate hypofractionation in high-risk breast cancer
3:07
Moderate hypofractionation in high-risk breast cancer
Icro Meattini • 30 May 2025
BRCA1 and BRCA2 carrier status: implications for breast cancer treatment
1:28
BRCA1 and BRCA2 carrier status: implications for breast cancer treatment
Icro Meattini • 30 May 2025

Related Videos

HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
QoL following hypofractionated adjuvant breast RNRT: insights from the HYPORT study
1:15
QoL following hypofractionated adjuvant breast RNRT: insights from the HYPORT study
Sanjoy Chatterjee • 17 May 2026
Adherence to weight loss intervention in breast cancer patients
1:09
Adherence to weight loss intervention in breast cancer patients
Jennifer Ligibel • 31 May 2026
The content of VJOncology is intended for healthcare professionals